BN83495
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BN83495, covering 2015-09-02 to 2015-09-30. Get the full timeline:
Most recent: Clinical Trial Update: The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer [Phase 2]